How Genetic Data is Transforming Cancer and Other Diseases
Setup
The idea of gathering DNA samples into a vast database in order to identify disease risks and breakthrough therapies was once a distant dream. Not long ago, immunotherapy seemed like pure fantasy. Today, these genetic-based approaches offer patients insights into their risks for developing cancer, potentially leading to new therapeutic approaches, earlier screenings, and prevention, all based on personalized data. Genetics are now a routine part of cancer care, and knowledge of immune biology is advancing swiftly. Drugs tailored to individual genetic profiles are already in clinical trials, aiming not only to treat lethal diseases, but perhaps also to prevent them. Pioneering researchers and entrepreneurs see a limitless scientific frontier.
Explore More
Science
From the debate over reproductive rights to the epidemic of gun violence to the youth mental health crisis, this year's Aspen Ideas: Health sessions tackled many of today's mo...
For as long as humans have looked at the skies, we’ve speculated about whether there is life in space. Scientists, the U.S. military and the CIA have all searched for proof of...
It sounds like sci-fi: Scientists are beaming solar energy from space, subbing seaweed for plastic and brightening clouds to reflect sunlight to lower temperatures in a warmin...
Artificial intelligence is revolutionizing health care by improving patient navigation, telehealth and the speed of drug development. From enhancing patient and provider exper...
*No food or service animals allowed in this session.* The creator of Fat Bear Week in Alaska gives insight on the importance of wildlife education, and then ecologists unpack...
Brain-computer interfaces show potential to restore function to people impacted by incurable neurological conditions such as stroke, spinal cord injury, traumatic brain injury...
Scientists are developing life-extending drugs for dogs, and new advancements could bring them to market by 2025. Two leaders working to slow the aging process for Fido discus...
Neurodivergent people make up 15% to 20% of the global population, and visionaries are busy trying to foster welcoming environments in areas like adaptive sports, fashion des...
Across the globe, humans are living and working longer than ever — and today’s systems, governments and businesses aren’t prepared. Examine how we can reimagine work, wealth a...
Given what we learned from the global turbulence from COVID-19, are we any more prepared for the next pandemic? Author and journalist Michael Lewis and Adar Poonawalla, CEO of...
Few people are more deeply steeped in science than Francis Collins, former director of the National Institutes of Health and the groundbreaking Human Genome Project, and forme...
Part 1. Contrary to Popular Opinion — Bill Maher in Real Time: The iconoclastic host of HBO’s “Real Time with Bill Maher” sits down with Tina Brown to talk about calling out...
Climate change is a threat multiplier with a disproportionate impact on vulnerable populations. Girls and women, who are denied equitable access to education and economic oppo...
Featuring inspiring conversations, the closing session is not to be missed. First, U.S. Surgeon General Vivek Murthy and Jennifer Ashton of ABC News explore the loneliness epi...
The experience of loss alters the map of the world imprinted on our brain, disrupting patterns and expectations as it struggles to form new ones. Grief is a kind of longing, n...
From in vitro fertilization (IVF), which combines human eggs and sperm outside the body, to in vitro gametogenesis (IVG), which uses stem cells to create gametes, pregnancy is...
The hormonal changes and hot flashes that accompany menopause are familiar to most women, but the accompanying brain changes have not received as much attention. We now know t...
The communities we call home and the ways we live greatly influence health and longevity. By studying “Blue Zones” around the globe, Dan Buettner has uncovered the macro-level...
The first drug in a class known as GLP-1 agonists was approved in 2005 to treat diabetes. GLP-1 drugs subsequently proved their mettle to treat obesity and prevent major cardi...
From the measles vaccine to the origins of COVID, the speed at which disinformation spreads and the harms it can do have become painfully familiar. Communicators are fighting...
